PubRank

N Sumi

Author PubWeight™ 13.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. J Biol Chem 1997 2.44
2 RIKEN integrated sequence analysis (RISA) system--384-format sequencing pipeline with 384 multicapillary sequencer. Genome Res 2000 1.50
3 Identification and characterization of STK12/Aik2: a human gene related to aurora of Drosophila and yeast IPL1. Cytogenet Cell Genet 1998 1.10
4 Spontaneous neoplastic lesions in aged Sprague-Dawley rats. Exp Anim 2001 1.07
5 An analysis of sit-to-stand movements. Arch Phys Med Rehabil 1993 1.05
6 Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells. J Invest Dermatol 1999 1.03
7 Verotoxin-producing Escherichia coli O157:H7 carried by the housefly in Japan. Med Vet Entomol 1999 0.96
8 cDNA cloning, characterization, and chromosome mapping of UBE2E2 encoding a human ubiquitin-conjugating E2 enzyme. Cytogenet Cell Genet 1997 0.93
9 Effect of inoculum size and frequency on the establishment of Streptococcus mutans in the oral cavities of experimental animals. J Dent Res 1988 0.86
10 A study of the central cavity in the bovine corpus luteum. Vet Rec 1988 0.83
11 [Food poisoning caused by enteroinvasive Escherichia coli (O164:H-)--a case in which the causative agent was identified]. Kansenshogaku Zasshi 1992 0.81
12 The incidence of spontaneous tumors of the central nervous system of Wistar rats. Arch Toxicol 1976 0.79
13 [Reproductive and developmental toxicity studies of montirelin hydrate (4)--Perinatal and postnatal study in rats by intravenous administration]. J Toxicol Sci 1995 0.78
14 [The prevalence of virulence-related genes, eaeA, aggR and astA, of localized and aggregative-adherent Escherichia coli (EPEC and EAggEC) in healthy children and age-matched patients with diarrhea]. Kansenshogaku Zasshi 2000 0.77
15 [Single dose toxicity studies of metabolite, degradation product and impurity of montirelin hydrate (NS-3) in mice]. J Toxicol Sci 1995 0.75
16 [Reproductive and developmental toxicity studies of montirelin hydrate (1)--Fertility study in rats by intravenous administration]. J Toxicol Sci 1995 0.75
17 [A photoallergenicity study of prulifloxacin (NM441) in guinea pigs]. J Toxicol Sci 1996 0.75
18 [Reproductive and developmental toxicity studies of lactitol (NS-4) (2)--Teratogenicity study in rats by oral administration]. J Toxicol Sci 1994 0.75
19 [Reproductive and developmental toxicity studies of prulifloxacin (NM441)(4)--A perinatal and postnatal study in rats by oral administration]. J Toxicol Sci 1996 0.75
20 [Single-dose toxicity studies of prulifloxacin (NM441) in mice, rats and dogs and the active metabolite (NM394) in rats]. J Toxicol Sci 1996 0.75
21 [Oral single-dose and 13-week repeat-dose toxicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in rats]. J Toxicol Sci 1997 0.75
22 [Effect of glucose on sucrose-induced dental caries in rats]. Shoni Shikagaku Zasshi 1985 0.75
23 [A 13-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 5-week recovery test]. J Toxicol Sci 1996 0.75
24 [Reproductive and developmental toxicity studies of lactitol (NS-4) (4)--Perinatal and postnatal study in rats by oral administration]. J Toxicol Sci 1994 0.75
25 Synergistic action of N-nitrosodialkylamines and near-UV in the induction of chromosome aberrations in Chinese hamster lung fibroblasts in vitro. Mutat Res 1995 0.75
26 [Renal toxicity of prulifloxacin (NM441) in rats]. J Toxicol Sci 1996 0.75
27 [Four-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 4-week recovery test]. J Toxicol Sci 1995 0.75
28 [52-week oral toxicity study of lactitol (NS-4) in dogs followed by 9-week recovery test]. J Toxicol Sci 1994 0.75
29 [Single dose toxicity study of lactitol (NS-4) in dogs]. J Toxicol Sci 1994 0.75
30 [Reproductive and developmental toxicity studies of prulifloxacin (NM441)(1)--A fertility study in rats by oral administration]. J Toxicol Sci 1996 0.75
31 [Caries-inducing activity of a maltitol-rich sweetener in the experimental dental caries of rats]. Shoni Shikagaku Zasshi 1985 0.75
32 [Antigenicity studies of prulifloxacin (NM441)]. J Toxicol Sci 1996 0.75
33 [Reproductive and developmental toxicity studies of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence (2). Teratogenicity study in rats by oral administration]. J Toxicol Sci 1997 0.75
34 [Caries-inducing activity of corn syrup in experimental dental caries]. Shoni Shikagaku Zasshi 1985 0.75
35 [Survey on area-to-area spread of influenza epidemics]. Kansenshogaku Zasshi 1987 0.75
36 [A 13-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 5-week recovery test]. J Toxicol Sci 1997 0.75
37 [Toxicokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice and rats during 13-week dietary administration]. J Toxicol Sci 1997 0.75
38 [The mechanism of increased thyroidal function caused by (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, administration in rats]. J Toxicol Sci 1997 0.75
39 Glycemic index determination of vegetable and fruits in healthy Bangladeshi subjects. Malays J Nutr 2011 0.75
40 [13-week oral toxicity study of lactitol (NS-4) in rats followed by 5-week recovery test]. J Toxicol Sci 1994 0.75
41 The mechanism of lactitol (NS-4) in inducing adrenomedullary proliferative lesion in rats. J Toxicol Sci 1995 0.75
42 [A 4-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 4-week recovery test]. J Toxicol Sci 1996 0.75
43 [A 26-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 9-week recovery test]. J Toxicol Sci 1997 0.75
44 [Reproductive and developmental toxicity studies of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence (3). Teratogenicity study in rabbits by oral administration]. J Toxicol Sci 1997 0.75
45 [Mutagenicity studies of (+/-)-4-diethylamino-1,1,-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence]. J Toxicol Sci 1997 0.75
46 [A 13-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in dogs followed by a 5-week recovery test]. J Toxicol Sci 1997 0.75
47 [Clinical and statistical survey of the children at the Pedodontic Clinic of the Osaka University Dental Hospital]. Osaka Daigaku Shigaku Zasshi 1985 0.75
48 [Single and 4-week oral toxicity studies of prulifloxacin (NM441) in aged dogs]. J Toxicol Sci 1996 0.75
49 Enhancement of the clastogenicity of N-nitrosodialkylamines plus near-ultraviolet irradiation by ethanol in Chinese hamster lung fibroblasts. Environ Mol Mutagen 1997 0.75
50 Seventy-eight-week dietary carcinogenicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice. J Toxicol Sci 1997 0.75
51 [A 12-month oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in dogs followed by a 2-month recovery test]. J Toxicol Sci 1997 0.75
52 [Caries-inducing activity of Palatinose syrup]. Shoni Shikagaku Zasshi 1985 0.75
53 [Reproductive and developmental toxicity studies of lactitol (NS-4) (3)--Teratogenicity study in rabbits by oral administration]. J Toxicol Sci 1994 0.75
54 [Reproductive and developmental toxicity studies of prulifloxacin (NM441)(3)--A teratogenicity study in rabbits by oral administration]. J Toxicol Sci 1996 0.75
55 [A 13-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 5-week recovery test]. J Toxicol Sci 1996 0.75
56 A case of multiloculated, intracranial epidermoid cyst in a beagle dog. Lab Anim 1991 0.75
57 [13-week oral toxicity study of lactitol (NS-4) in dogs followed by 4-week recovery test]. J Toxicol Sci 1994 0.75
58 [Mutagenicity studies of lactitol (NS-4)]. J Toxicol Sci 1994 0.75
59 [Single dose toxicity studies of montirelin hydrate(NS-3) in mice, rats and dogs]. J Toxicol Sci 1995 0.75
60 [Reproductive and developmental toxicity studies of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence (1). Fertility study in rats by oral administration]. J Toxicol Sci 1997 0.75
61 Forelimb paralysis due to spontaneously developed astrocytoma in the spinal cord of a Sprague Dawley rat. Lab Anim Sci 1994 0.75
62 [Single dose toxicity studies of lactitol (NS-4) in mice and rats]. J Toxicol Sci 1994 0.75
63 [Five-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 4-week recovery test]. J Toxicol Sci 1995 0.75
64 [Single-dose toxicity studies of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice, rats and dogs]. J Toxicol Sci 1997 0.75
65 [Reproductive and developmental toxicity studies of montirelin hydrate (2)--Teratogenicity and postnatal study in rats by intravenous administration]. J Toxicol Sci 1995 0.75
66 [52-week oral toxicity study of lactitol (NS-4) in rats followed by 9-week recovery test]. J Toxicol Sci 1994 0.75
67 [Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 9-week recovery test]. J Toxicol Sci 1995 0.75
68 [A 4-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 4-week recovery test]. J Toxicol Sci 1996 0.75
69 [Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence]. J Toxicol Sci 1997 0.75
70 [Transmission and establishment of Streptococcus mutans in an experimental animal system]. Shoni Shikagaku Zasshi 1986 0.75
71 [Mutagenicity studies of montirelin hydrate (NS-3)]. J Toxicol Sci 1995 0.75
72 Effect of mutacin administration on Streptococcus mutans-induced dental caries in rats. Microbiol Immunol 1985 0.75
73 [Reproductive and developmental toxicity studies of lactitol (NS-4) (1)--Fertility study in rats by oral administration]. J Toxicol Sci 1994 0.75
74 [Mutagenicity studies of prulifloxacin (NM441) and the active metabolite (NM394)]. J Toxicol Sci 1996 0.75
75 Maternal transmission and dental caries induction in Sprague-Dawley rats infected with Streptococcus mutans. Microbiol Immunol 1988 0.75
76 [Reproductive and developmental toxicity studies of prulifloxacin (NM441)(2)--A teratogenicity study in rats by oral administration]. J Toxicol Sci 1996 0.75
77 [Reproductive and developmental toxicity studies of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence (4). Perinatal and postnatal study in rats by oral administration]. J Toxicol Sci 1997 0.75
78 [Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 9-week recovery test]. J Toxicol Sci 1995 0.75
79 [Vascular irritability study of montirelin hydrate (NS-3) injection in rabbits]. J Toxicol Sci 1995 0.75
80 [A 4-week intravenous toxicity study of the active metabolite (NM394) of prulifloxacin (NM441) in rats followed by a 4-week recovery test]. J Toxicol Sci 1996 0.75
81 [Reproductive and developmental toxicity studies of montirelin hydrate (3)--Teratogenicity study in rabbits by intravenous administration]. J Toxicol Sci 1995 0.75
82 Two-year dietary carcinogenicity study of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats. J Toxicol Sci 1997 0.75
83 [Intraperitoneal single-dose toxicity studies of active metabolite, optical isomers, hydrolysis products and bi-product of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice]. J Toxicol Sci 1997 0.75